A therapeutic nanoparticle vaccine againstTrypanosoma cruziin a BALB/c mouse model of Chagas disease-Reference-Cited by-同舟云学术

A therapeutic nanoparticle vaccine againstTrypanosoma cruziin a BALB/c mouse model of Chagas disease

Published:2016-02-18 Issue:4 Volume:12 Page:976-987
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Barry Meagan A.,Wang Qian,Jones Kathryn M.,Heffernan Michael J.,Buhaya Munir H.,Beaumier Coreen M.,Keegan Brian P.,Zhan Bin,Dumonteil Eric,Bottazzi Maria Elena,Hotez Peter J.

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/21645515.2015.1119346

Reference63 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

2. Global economic burden of Chagas disease: a computational simulation model

3. Chagas disease

4. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory activity of two Trypanosoma cruzi recombinant antigens TSA-1-C4 and Tc24-C4 induce activation of macrophages and CD8+ T cells;2024-08-19

2. Alternative Approaches for the Treatment of Chagas Disease;ChemistrySelect;2024-05-06

3. Microalgae‐made human vaccines and therapeutics: A decade of advances;Biotechnology Journal;2024-05

4. Chagas Disease: A Silent Threat for Dogs and Humans;International Journal of Molecular Sciences;2024-03-29

5. Protective efficacy of the oral vaccine Tc24:Co1 produced in Schizochytrium sp. against Trypanosoma cruzi infection in a mouse model;Microbial Pathogenesis;2024-01